Pei-Jen Chang

Pei-Jen (PJ) Chang is a seasoned professional in the field of clinical operations and research quality, currently serving as Director of Research & Development Quality at Gilead Sciences since March 2021, focusing on quality processes and regulatory compliance within Clinical Data Science. Prior experience includes a Program Project Management Consultant role at GLG from 2015 to 2022, advising on strategic operational issues across various clinical research topics. Previous positions at Stanford Cancer Institute involved leadership in clinical trial operations, quality control measures, and oversight of vendor management, while earlier roles at Kaiser Permanente and the University of California, Davis included clinical research coordination and cancer prevention research. PJ Chang holds degrees from Stanford University Graduate School of Business and the University of California, Davis.